» Articles » PMID: 34837059

Receptome Profiling Identifies KREMEN1 and ASGR1 As Alternative Functional Receptors of SARS-CoV-2

Abstract

Host cellular receptors play key roles in the determination of virus tropism and pathogenesis. However, little is known about SARS-CoV-2 host receptors with the exception of ACE2. Furthermore, ACE2 alone cannot explain the multi-organ tropism of SARS-CoV-2 nor the clinical differences between SARS-CoV-2 and SARS-CoV, suggesting the involvement of other receptor(s). Here, we performed genomic receptor profiling to screen 5054 human membrane proteins individually for interaction with the SARS-CoV-2 capsid spike (S) protein. Twelve proteins, including ACE2, ASGR1, and KREMEN1, were identified with diverse S-binding affinities and patterns. ASGR1 or KREMEN1 is sufficient for the entry of SARS-CoV-2 but not SARS-CoV in vitro and in vivo. SARS-CoV-2 utilizes distinct ACE2/ASGR1/KREMEN1 (ASK) receptor combinations to enter different cell types, and the expression of ASK together displays a markedly stronger correlation with virus susceptibility than that of any individual receptor at both the cell and tissue levels. The cocktail of ASK-related neutralizing antibodies provides the most substantial blockage of SARS-CoV-2 infection in human lung organoids when compared to individual antibodies. Our study revealed an interacting host receptome of SARS-CoV-2, and identified ASGR1 and KREMEN1 as alternative functional receptors that play essential roles in ACE2-independent virus entry, providing insight into SARS-CoV-2 tropism and pathogenesis, as well as a community resource and potential therapeutic strategies for further COVID-19 investigations.

Citing Articles

SARS-CoV-2 Impairs Osteoblast Differentiation Through Spike Glycoprotein and Cytokine Dysregulation.

Freiberger R, Lopez C, Jarmoluk P, Palma M, Cevallos C, Sviercz F Viruses. 2025; 17(2).

PMID: 40006897 PMC: 11860324. DOI: 10.3390/v17020143.


Plasma proteins and herpes simplex virus infection: a proteome-wide Mendelian randomization study.

Fu C, Xu W, Xu X, Zhao F, Zheng C, Yin Z Virus Genes. 2025; .

PMID: 39992613 DOI: 10.1007/s11262-025-02145-3.


Cyclophilin-CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8.

Tajti G, Gebetsberger L, Pamlitschka G, Aigner-Radakovics K, Leitner J, Steinberger P Front Immunol. 2025; 16:1460089.

PMID: 39963132 PMC: 11830813. DOI: 10.3389/fimmu.2025.1460089.


Cell surface protein-protein interaction profiling for biological network analysis and novel target discovery.

Chen J, Fang M, Li Y, Ding H, Zhang X, Jiang X Life Med. 2025; 3(4):lnae031.

PMID: 39872863 PMC: 11749001. DOI: 10.1093/lifemedi/lnae031.


COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis.

Tang Z, Chen Y, Ouyang Y, Peng Y, Man X World Allergy Organ J. 2025; 18(1):101022.

PMID: 39867872 PMC: 11758953. DOI: 10.1016/j.waojou.2024.101022.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

3.
Li W, Moore M, Vasilieva N, Sui J, Wong S, Berne M . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450-4. PMC: 7095016. DOI: 10.1038/nature02145. View

4.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

5.
Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L . Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592. PMC: 7240771. DOI: 10.1056/NEJMc2011400. View